NDC 0169-7013

TRETTEN

Coagulation Factor Xiii A-subunit (recombinant)

TRETTEN is a Kit in the Plasma Derivative category. It is labeled and distributed by Novo Nordisk. The primary component is .

• Product ID: 0169-7013_4e209c90-8c47-406a-98f4-d3803c350d8a
• NDC: 0169-7013
• Product Type: Plasma Derivative
• Proprietary Name: TRETTEN
• Generic Name: Coagulation Factor Xiii A-subunit (recombinant)
• Dosage Form: Kit
• Marketing Start Date: 2013-12-23
• Marketing Category: BLA / BLA
• Application Number: BLA125398
• Labeler Name: Novo Nordisk
• Active Ingredient Strength: 0
• NDC Exclude Flag: N
• Listing Certified Through: 2021-12-31

Packaging

NDC 0169-7013-01

1 KIT in 1 KIT (0169-7013-01) * 3 mL in 1 VIAL, GLASS (0169-7113-11) * 3.2 mL in 1 VIAL, GLASS (0169-7000-93)

• Marketing Start Date: 2013-12-23
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 0169-7013-01 [00169701301]

TRETTEN KIT

• Marketing Category: BLA
• Application Number: BLA125398
• Product Type: PLASMA DERIVATIVE
• Billing Unit: EA
• Marketing Start Date: 2013-12-23

Drug Details